Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of MASH and other diseases in France, the United States, and Internationally. It develops Lanifibranor, for the treatment of patients with metabolic dysfunction-associated steatohepatitis, a progressive, chronic liver disease, which is in Phase III clinical trial; and Odiparcil for the treatment of patients with mucopolysaccharidoses, or MPS, a group of rare genetic disorders characterized by an excessive accumulation of large sugar chains, known as glycosaminoglycans, or GAGs, in cells. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was incorporated in 2011 and is headquartered in Daix, France.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [12/01/2025 06:58 PST] IVA Expected to Trade Up After Bullish Patterns Develop
• [11/25/2025 10:29 PST] Inventiva S.A. (NASDAQ:IVA), Up By 100% ($4.01) From $4.01 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [11/13/2025 11:45 PST] Inventiva S.A. (NASDAQ:IVA), Down By 100% ($4.16) From $4.16 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [11/13/2025 06:49 PST] IVA Expected to Trade Up After Bullish Patterns Develop
• [11/10/2025 07:39 PST] IVA Expected to Trade Up After Bullish Patterns Develop
• [10/30/2025 07:03 PDT] IVA Expected to Trade Down After Bearish Patterns Develop
• [10/27/2025 13:58 PDT] Inventiva S.A. (NASDAQ:IVA), Up By 100% ($6.24) From $6.24 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/27/2025 11:45 PDT] Inventiva S.A. (NASDAQ:IVA), Up By 100% ($5.87) From $5.87 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/24/2025 07:31 PDT] IVA Expected to Trade Up After Bullish Patterns Develop
• [10/23/2025 12:42 PDT] Inventiva S.A. (NASDAQ:IVA), Up By 100% ($5.11) From $5.11 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/23/2025 12:42 PDT] Inventiva S.A. (NASDAQ:IVA), Up By 100% ($5.2) After BUYINS.NET SqueezeTrigger Report Released on Monday, October 20th 2025 at a Price of $5.195.
• [10/23/2025 12:42 PDT] Inventiva S.A. (NASDAQ:IVA), Up By 100% ($5.11) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, October 15th 2025 at a Price of $5.11.
• [10/22/2025 16:30 PDT] Inventiva S.A. (NASDAQ:IVA), Up By 100% ($4.85) From $4.85 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/20/2025 15:33 PDT] IVA SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [10/17/2025 07:17 PDT] IVA Expected to Trade Up After Bullish Patterns Develop
• [10/15/2025 13:17 PDT] IVA Expected to Trade Up After Bullish Patterns Develop
• [10/15/2025 12:23 PDT] IVA SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [10/10/2025 10:29 PDT] Inventiva S.A. (NASDAQ:IVA), Down By 100% ($5.52) From $5.52 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [10/08/2025 07:09 PDT] IVA Expected to Trade Down After Bearish Patterns Develop
• [10/07/2025 07:29 PDT] IVA Expected to Trade Up After Bullish Patterns Develop